NEJM Interviews

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

http://www.nejm.org/multimedia/audio-interview

Eine durchschnittliche Folge dieses Podcasts dauert 11m. Bisher sind 806 Folge(n) erschienen. Jede Woche gibt es eine neue Folge dieses Podcasts.

Gesamtlänge aller Episoden: 8 days 21 minutes

subscribe
share






NEJM Interview: Elizabeth Nash on state-level abortion restrictions, including recent efforts that directly challenge Roe v. Wade.


Elizabeth Nash is the senior state issues manager at the Guttmacher Institute. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Nash. Abortion Rights in Peril — What Clinicians Need to Know. N Engl J Med 2019;381:497-499.


share








 August 7, 2019  9m
 
 

NEJM Interview: Dr. Katherine A. High on gene therapy for genetic disease.


Dr. Katherine High is Emeritus Professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania and president and head of research and development at Spark Therapeutics. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K.A. High and M.G. Roncarolo. Gene Therapy. N Engl J Med 2019;381:455-464.


share








 July 31, 2019  15m
 
 

NEJM Interview: Dr. Deborah Anderson on the potential for new contraceptive methods to ease problems associated with population growth.


Dr. Deborah Anderson is a professor of obstetrics and gynecology, microbiology, and medicine at the Boston University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.J. Anderson. Population and the Environment — Time for Another Contraception Revolution. N Engl J Med 2019;381:397-399.


share








 July 31, 2019  6m
 
 

NEJM Interview: Dr. Pieter Cohen on the legal status of cannabidiol and an opportunity to strengthen the FDA’s approach to safety requirements for new dietary ingredients.


Dr. Pieter Cohen is an associate professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.A. Cohen and J. Sharfstein. The Opportunity of CBD — Reforming the Law. N Engl J Med 2019;381:297-299.


share








 July 24, 2019  7m
 
 

NEJM Interview: Dr. Anita Berlin on the relationship between the state and medical care and maintaining the integrity of the medical code of ethics.


Anita Berlin is a professor of primary care education at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Berlin and Others. The Right and Left Hands of the State — Two Patients at Risk of Deportation. N Engl J Med 2019;381:197-201.


share








 July 17, 2019  14m
 
 

NEJM Interview: Dr. Julie Cantor on steps taken by local governments to control the spread of measles.


Dr. Julie Cantor is an adjunct professor at the UCLA School of Law. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Cantor. Mandatory Measles Vaccination in New York City — Reflections on a Bold Experiment. N Engl J Med 2019;381:101-103. R.D. Silverman, D.J. Opel, and S.B. Omer. Vaccination over Parental Objection — Should Adolescents Be Allowed to Consent to Receiving Vaccines? N Engl J Med 2019;381:104-106.


share








 July 10, 2019  22m
 
 

NEJM Interview: Dr. Evan E. Eichler on genetic variation, comparative genomics, and the diagnosis of disease.


Dr. Evan Eichler is Professor of Genome Sciences at the University of Washington. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.E. Eichler. Genetic Variation, Comparative Genomics, and the Diagnosis of Disease. N Engl J Med 2019;381:64-74.


share








 July 3, 2019  7m
 
 

NEJM Interview: Dr. Roy Perlis on esketamine as an option for treatment-resistant depression.


Dr. Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Kim and Others. Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class. N Engl J Med 2019;381:1-4.


share








 July 3, 2019  8m
 
 

NEJM Interview: Dr. Jonathan Oberlander on the latest legal challenge to the Affordable Care Act and the ongoing health policy stalemate in Washington.


Dr. Jonathan Oberlander is a professor of social medicine and health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Oberlander. Sitting in Limbo — Obamacare under Divided Government. N Engl J Med 2019;380:2485-2487.


share








 June 26, 2019  7m
 
 

NEJM Interview: Dr. Héctor Carrasco on strategies for uncovering and addressing the fundamental causes of complex health problems.


Dr. Héctor Carrasco is a physician and a doctor of public health candidate at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. H. Carrasco, L. Messac, and S.M. Holmes. Misrecognition and Critical Consciousness — An 18-Month-Old Boy with Pneumonia and Chronic Malnutrition. N Engl J Med 2019;380:2385-2389.


share








 June 19, 2019  10m